Siereńska Joanna, Sotomska Zofia, Madej-Łukasiak Dorota, Wąż Piotr, Grzybowska Magdalena Emilia
Department of Gynecology, Obstetrics and Neonatology, Medical University of Gdańsk, Smoluchowskiego 17, 80-214 Gdańsk, Poland.
Independent Team of Physiotherapists, University Clinical Center, Al. Zwycięstwa 30, 80-219 Gdańsk, Poland.
J Clin Med. 2023 Sep 20;12(18):6077. doi: 10.3390/jcm12186077.
Perineal pain occurs in 97% of women with episiotomy or first- and second-degree perineal tears on the first day after delivery. The study aimed to assess the impact of capacitive and resistive energy transfer (TECAR) on perineal pain and discomfort in the first two postpartum days. The prospective randomized double-blind study was performed with the pain and discomfort assessment using the Visual Analogue Scale at baseline and after both TECAR interventions. Characteristics data, delivery information, and the number of painkillers taken were collected. The assumed significance level was α < 0.05. The study included 121 women with a mean age of 30.7 ± 4.2 years and a median BMI of 26.1 kg/m (24.1; 28.9). Pain reduction at rest, when walking, and discomfort reduction when walking were significantly higher in the TECAR group compared to the sham group ( < 0.05). After the first TECAR intervention, significant reduction in all measured parameters was observed in the study group ( < 0.03), whereas in the control group, it was observed in pain and discomfort while sitting ( < 0.04). The amount of ibuprofen taken on the second day was significantly reduced in the study group compared to the first day ( = 0.004). TECAR has been shown to provide more immediate and significant reduction in perineal pain and discomfort.
97%接受会阴切开术或一度和二度会阴撕裂的女性在分娩后的第一天会出现会阴疼痛。该研究旨在评估电容式和电阻式能量转移（TECAR）对产后前两天会阴疼痛和不适的影响。采用前瞻性随机双盲研究，在基线时以及两次TECAR干预后使用视觉模拟量表进行疼痛和不适评估。收集了特征数据、分娩信息以及服用止痛药的数量。假定的显著性水平为α<0.05。该研究纳入了121名女性，平均年龄为30.7±4.2岁，体重指数中位数为26.1kg/m²（24.1；28.9）。与假手术组相比，TECAR组在休息时、行走时的疼痛减轻以及行走时的不适减轻更为显著（P<0.05）。在第一次TECAR干预后，研究组所有测量参数均显著降低（P<0.03），而在对照组中，仅在坐着时的疼痛和不适方面有显著降低（P<0.04）。与第一天相比，研究组第二天布洛芬的服用量显著减少（P = 0.004）。结果表明，TECAR能更迅速且显著地减轻会阴疼痛和不适。
